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Absract: Aim: In present study, we aimed to compare the staged and combined surgery in patients with severe carotid 
stenosis and coronary atherosclerosis and detect the factors affecting mortality and morbidity. 
Material and method: Between 2004 and 2008, 120 patients with predominant ischemic heart disease were enrolled to 
study. Patients were divided into three groups on basis surgery procedure. Group 1 (n=40) includeed patients had coronary 
artery disease without carotid disease underwent coronary artery by-pass graft (CABG) operation. Group 2 (n=40): in-
cluded patients underwent combined surgery procedure including CABG and carotid endarterectomy (CEA). Patients un-
derwent staged CABG and CEA were enrolled to Group 3 (n=40). All patients were in advanced aged and were had the 
same risk factors atributable atherosclerosis 
Results: Mean age of the patients in all groups were 68±6, 69±3, 71±2 respectively, and 83% were male. Eight patients 
died in all groups at follow-up(seven in group 2 and 3, and one in group 1) and the difference between both groups was 
statistically significant (p<0.001). The follow-up period in the intensive care unit, and hospitalization period were not sta-
tistically different between CABG group and combined CEA plus CABG group. 
Conclusion: We think that the results of staged or combined CABG plus CEA surgery are satisfactory in patients with se-
vere carotid disease and advanced coronary artery disease. However, the mortality and morbidity in both procedures are 
higher than those of alone.  
INTRODUCTION 
  Cardiovascular diseases are the most cause of death in 
the developed countries. Modeling
  studies in many devel-
oped countries, particularly the United
 States, Netherlands, 
New Zealand, and United Kingdom, suggest
  that 55% to 
65% of recent, substantial CHD mortality declines
  can be 
attributed to declines in major risk factors, the remainder
 
being attributable to medical and surgical treatments [1]. In 
the USA 39.4% of all of deaths is due to cardiovascular dis-
eases and coronary heart diseases account for the the biggest 
part (54%) of cardiovascular disease leading death of cardio-
vascular diseases. In addition, 18% of cardiovascular caused 
deaths is due to stroke [2]. Postoperatif neurological problem 
is one of the serious complication of cardiac surgery. Fre-
quency of serious perioperative neurological complication 
among patients undergoing coronary artery bypass surgery 
has been determined in range of 0.5% - 7% [2-4]. The possi-
ble mechanisms of neurological complication seen after   
elective CABG surgery are decrease in the brain blood flow 
due to hypotension or hypoperfusion, macro or micro em-
bolisation and intracranial or extracranial vascular disease 
cause cerebrovascular event [5]. Although carotid arterial 
stenosis is seen in 2.4%- 14% of patients with coronary artery 
disease undergoing CABG; coronary artery disease is seen 
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in 40%-50% of patients undergoing carotid endarterektomy 
(CEA) [6-9]. Berens et al. l reported that stroke was seen by 
rate of 10.9% in >65 years old patients with >80% carotid 
arterial stenosis [10]. The frequency of perioperative myo-
cardial enfarction in patients underwent isolated CEA has 
been determined in range of 1.5% to 5% [11]. CEA is rec-
ommended in patients with symptomatic carotid disease un-
dergoing CABG due to coronary artery disease, but it is not 
well determined which procedure including staged or com-
bined CEA plus CABG should be performed in current lit-
erature. The mechanism for stroke in patients with asymp-
tomatic serious carotid stenosis undergoing CABG is still 
controversial [12]. In present study, we aimed to compare 
the staged and combined surgery in patients with severe ca-
rotid stenosis and coronary atherosclerosis and detect the 
factors affecting mortality and morbidity. 
MATERIALS AND METHOD 
  Between May 2004 and February 2008, 120 patients with 
predominant ischemic heart disease were enrolled to study. 
Group 1 (n=40) includeed patients had coronary artery dis-
ease without carotid disease underwent coronary artery by-
pass graft (CABG) operation. Group 2 (n=40): included pa-
tients underwent combined surgery procedure including 
CABG and carotid endarterectomy (CEA). Patients under-
went staged CABG and CEA were enrolled to Group 3 
(n=40). The approval of the ethical commitee of our hospital 
and informed concent from all patients were taken. All pa-
tients were in advanced aged and were had the same risk Early Results of Combined and Staged Coronary Bypass and Carotid  The Open Cardiovascular Medicine Journal, 2009, Volume 3    9 
factors atributable atherosclerosis. All groups were compared 
in terms of preoperative risk factors, operative technique, 
preoperative and postoperative morbidity, mortality, and the 
factors affecting this parameters. 
Preoperative Evaluation 
  58.9% of patients has been expiriencing chronical angina 
pectoris which is in the class II-III accarding to Canadian 
classification. Eighteen patients in the group 2, and 16 pa-
tients in group 3 were neurologically asymptomatic. Firstly, 
coloured dupplex ultrasonografy, and then carotid digital 
substraction anjiografy were performed to all patients under-
going CEA. In 5 patients Type A ulcerated lesion was found 
by Dupplex ultrasonografy, and in remain >70% carotid 
stenosis was found (Table 1).  
 
Table 1.  Distribution of Carotid Lesions 
  Number of Patients 
Bilateral %50-70  1*
 
Unilateral %50-70  4*
 
Bilateral right or left side >%70  3 
Unilateral or bilateral <%50  - 
Unilateral>%70 71 
Bilateral >%70  1 
*Patient with ulcerated plaque.  
Anesthesia and Surgical Technique 
  Coronary revascularization and CEA procedures were 
performed in all patients in simultaneous fashion under gen-
eral anesthesia. The same surgeons and operative team per-
formed all procedures. Routine CABG and CEA protocol of 
our cardiovascular surgery clinic was applied to all patients. 
Anesthesia was induced with 20 mcg/kg fentanyl citrate, 
0.12 mg/kg pancuronium, 2 mg/kg propofol. After tracheal 
intubation, mechanical ventilation was institued with 6-8 
ml/kg tidal volume and 10-12 /min respiratory rates. Anes-
thesia was maintained with 10 mcg/kg of fentanyl and 1 
mg/kg propofol as infusion. 2 mg of pancuronium were 
given every 45 minutes throughout the operation. Five elec-
troencephalographic (EEG) leads were placed and EEGS 
were monitored continuously with a Life Scan brain activity 
monitor (Diatek Patient Management System, Inc., SanDi-
ego, CA). In all patients CEAs were performed prior to ster-
notomy. In case of bilateral internal carotid artery lesions, we 
performed CEA on the side with the higher degree lesion, 
the side related to neurological symptoms, or the dominant 
hemisphere. CEA was not performed in patients had totally 
occluded carotid vessels. Saphenous vein grafts were pre-
pared during CEA. A standard oblique cervical incision was 
made. After isolation of the common, internal, and external 
carotid arteries, 2 ml of heparin was administered. Vessels 
were clamped and an arteriotomy was created in the common 
carotid artery and extended into the internal carotid artery. 
Changes in the electroencephalogram pattern after cross 
clamping not leading to an increase in the mean arterial pres-
sure were considered indications for intraluminal shunting. 
Intraluminal carotid shunt was not needed in any patient. The 
artery was opened beyond the distal extent of the plaque. 
The plaque was removed in the standard fashion. If the ar-
tery was thought to be small, the arteriotomy was closed 
with a saphenous vein patch. After completion of the CEA, 
the neck incision was left open until heparin reversal after 
CPB. After performing CEA, CPB was instituted with stan-
dard techniques. Aortic and two stage venous canulla were 
used to institute the CPB using a roller pump, membrane 
oxygenation and identical priming solution. Systemic blood 
flow was maintained at 2.2-2.4 L/m, mean arterial blood 
pressure at 60-70 mm Hg during CPB. Systemic hypother-
mia (28ºC) and hemodilution were applied. Distal anasto-
moses were done during the cross clamp (CC) period. 
Proximal anastomoses were done with partial occluding 
clamp in beating heart. The left anterior descending artery in 
all patients anatomosed with left internal mammarian artery 
flaps. The other vessels anastomosed with greater saphenous 
vein grafts. Postoperatively pharmacological support was 
instituted according to haemodynamic situation. The peri-
cardial (No:28) and mediastinal (No:32) chest tubes were 
inserted to all patients.  
  In group 3 including patients undergoing staged surgery, 
CEA was performed firstly, and CABG was performed two 
days later. However, both surgery were performed at same 
time without delaying in unstable patients. 
Statistical Analysis 
  Statistical analysis was performed with SPSS software 
version 10.0 (SPSS Inc, Chicago, III). Clinical data were 
expressed as mean values ± standard deviation, percents. 
Differences between the groups were investigated by Levine 
test, Bonferroni corrected t-test and Chi- Square test. Both 
groups and parameters inside each groups were compared 
using nonparametric Wilcoxon Signed Ranks test (two 
tailed). We investigated the effects of the variables by calcu-
lating odds ratios in univariate analyses for all patients. Dif-
ferences were considered as significant if p value <0.05. 
Univariate analyses of demographics and variables to iden-
tify potential stroke risk factors was performed by the stu-
dent’s t test, Wilcoxon Signed Ranks test or the X
2 test. Mul-
tivariate determinants of the stroke were obtained by the 
stepwise multivariate logistic regresyon analysis. Candidate 
variables with a value of p0.20 were entered into a logistic 
model. Regression coefficiencies that are significantly dif-
ferent from 1.00 (p0.05) in the completed model are con-
sidered associated with stroke. Odds rations and 95% confi-
dence limits as well as probability values, are reported. 
RESULTS 
  Mean age of the patients in all groups were 68±6, 69±3, 
71±2 respectively, and 83% were male. Demographical vari-
ables such as age, sex, and preoperative risk factors in 
groups were given on Table 2. Among the preoperative risk 
factors, having diabetes mellitus, systemic hypertension, 
hyperlipidemia, unstable angina pectoris, left main coronary 
arterial disease, cerebrovascular event and chronic obstruc-
tive pulmonary disease were significantly higher in com-
bined (group 2) or staged (group 3) CABG plus CEA groups 
compared only CABG group (group 1) (Table 2).  
  In 5 patients unilateral CEA plus CABG and in 75 pa-
tients bilateral CEA plus CABG were performed. The mor-10    The Open Cardiovascular Medicine Journal, 2009, Volume 3  Iyem and Buket 
tality was recorded in one patient due to arrythmia in group 3 
and in seven patients in group 2. In this study, patchplasty 
was done in 12 of 80 (10%) patients underwent CEA, in re-
main, the incision of carotid artery was closed primarily. The 
mean clamping time was 21.24±6.05 (ranged 15 to 36 min-
utes) (Table 3). 
  The compared perioperative and potoperative variables in 
three groups were shown in Table 4. The follow-up time in 
the intensive care unit, and duration of hospitalization were 
not statistically different between CABG group (group 1) 
and CEA plus CABG groups (group 2 and 3). No case of 
bleeding or hematoma was recorded at incision side.  
  In our study mortality was occured in 8 patients (seven in 
group 2 and 3, and one in group 1). This difference between 
CABG alone and CABG plus CEA groups in term of mortal-
itys was statistically significant(p<=.001). 
Table 3.  Operative Variables of Carotid Endarterectomy 
  Patient (n=)  
Unilateral carotid stenosis  75(%93.75)
 
Right carotid endarterectomy  39(%48.75)
 
Left carotid endarterectomy  36(%45.0) 
Bilateral carotid stenosis  5(%6.25) 
EEG monitoring  80(%100) 
Patchplasty 12(%15.0) 
Primary closure  68(%85.0) 
Carotid clamping time (min) mean±SD  21.24±6.05 
 
Table 2.  Demographics and Preoperative Factors of the Patients 
  Only CABG  Combined CEA+ CABG  Staged CEA+CABG  P Value 
Number  of  patients  40 40 40 - 
Age (mean ± SD)   68±6  69±3  71±2  a=ns, b=ns, c=ns 
Male    31(%77.5) 32(%80.0) 34(%85.0) a=ns,  b=ns,  c=ns 
Female  9(%22.5)  8(%20.0)  6 (%15.0)  a=ns, b=ns, c=ns 
Coronary Risk Factors 
Diabetes  mellitus  25(%62.5) 34(%85.0) 36(%90.0) a<0.05,b<0.05,  c=ns 
Hypertension    26(%65.0) 33(%82.5) 32(%80.0) a<0.05,b<0.05,  c=ns 
Hyperlipidemia    25(%62.5) 34(%85.0) 31(%77.5) a<0.05,b<0.05,  c=ns 
Smoking   32(%80)  37(%92.5)  38(%95.0)  a=ns, b=ns, c=ns 
Comorbidity 
Cerebrovascular  accident    1(%2.5)  6(%15.0) 7(%17.5) a<0.05,b<0.05,  c=ns 
Peripheral vascular disease   1(%2.5)  2(%5.0)  1(%2.5)  a=ns, b=ns, c=ns 
COPD    12(%30.0) 21(%52.5) 24(%60)  a<0.05,b<0.05,  c=ns 
Peptic/gastric  ulcer    1(%2.5) 3(%7.5) 2(%5.0) a=ns,  b=ns,  c=ns 
Cancer   1(%2.5) -  1(%2.5) a=ns,  b=ns,  c=ns 
Cardiac Profile  
 Preoperative MI  5(%12.5)  7(%17.5)  6(%15.)  a=ns, b=ns, c=ns 
Atrial fibrillation   2(%5.0)  1(%2.5)  3(%7.5)  a=ns, b=ns, c=ns 
LVEF(%) 43.1±11.3 45.3±16.1 47.5±9.2  a=ns,  b=ns,  c=ns 
LMC  3(%7.5)  9(%22.5) 8(%20.0) a<0.05,  b<0.05,  c=ns 
Unstabil anjina pectoris  3(%7.5)  7(%17.5)  9(%22.5)  a<0.05, b<0.05, c=ns 
Laboratory Data 
Creatinine level (mg/dL)  1.1±0.5  1.3± 0.6   1.0± 0.9  a=ns, b=ns, c=ns 
BUN level (mg/dL)  55.2±18.7   59.3±12.3   52± 11.4  a=ns, b=ns, c=ns 
COPD: Chronic obstructive pulmonary disease, BUN: Blood urea nitrogen, 
LVEF: Left ventricular ejection fraction, MI: Myocardial infarction, ns: not significant, 
a: p value for group Only CABG versus group Combined CEA+ CABG.  
b: p value for group Only CABG versus group Staged CEA+ CABG.  
c: p value for group Combined CEA+ CABG versus group Staged CEA+ CABG. Early Results of Combined and Staged Coronary Bypass and Carotid  The Open Cardiovascular Medicine Journal, 2009, Volume 3    11 
  On the univariate analysis, among the preoperative risk 
factors diabetes mellitus, hypertension, hyperlipidemia, 
chronic obstructive lung disease, history of cerebrovascular 
disease, left main coronary artery disease, unstable angina 
pectoris, and among the postoperative risk factors, stroke, 
reexploration due to bleeding and arrythmia were found as 
factors affecting on mortality (Tables 2-5). However, on 
multivariate analysis, among the perioperative risk factors 
history of serebrovascular disease, left main coronary artery 
disease and among the postoperative risk factors stroke were 
found to as factors affecting mortality with statistical signifi-
cance(p=0.002, p=0.032, p=0.005, respectively) (Table 6). 
No statistically significant difference was found when the 
staged and combined CEA plus CABG groups compared in 
terms of stroke and neurological deficit. Postoperative stroke 
was seen in two patients in combined CEA plus CABG 
group, and in three patients in staged CEA plus CABG group 
(Table 5). 
Table 4.  Operative and Postoperative Variables 
  Only CABG  Combined CEA+ CABG  Staged CEA+CABG  P value 
Cross clamp time(min)  41.2±20.9 44.9±11.6 42.9±14.2 ns 
CPB time (min)  61.7±24.7 62.2±32.7 59.9±21.8 ns 
Graft number (n)  3.04±0.8 3.1±0.7 3.06±0.6 ns 
Perioperative  MI  (n=)  1(%2.5) 2(%5.0) 1(%2.5)  ns 
Ventilation time (hr)  14.4±10.2 13.8±11.4 13.8±11.4 ns 
Mediastinal drainage (mL)  639.8±36.3 652±23.2 625.6±17.5 ns 
IIABP  (n=) 3(%7.5)  4(%10.0) 2(%%5.0)  ns 
ICU stay (hour)   22.7±16.7  25.3±43.2  27.4±43.5  ns 
Hospital stay (day)  7.1±2.6  7.3±8.8  7.5±5.6  ns 
Early mortality (n=)  1(%2.5)  3(%7.5)
a 4(%10.0)
b ns 
Bonferroni corrected t-test: no significant differences between groups. 
CPB: Cardiopulmonary bypass ICU: Intensive care unit, MI: Myocardial infarction,  
IIABP: Intraoperative intraaortic bollon pump. 
ns: not significant. 
a: p value for group Combined CEA+ CABG versus group Only CABG. 
b: p value for group Staged CEA+ CABG versus group Only CABG.  
 
Table 5.  Postoperative Complications and Factors Affecting Morbidity and Mortality 
Complications  Only CABG N=  Combined CEA+ CABG N=  Staged CEA+CABG N=  P value 
Acute renal failure   2(%5)  3(%7.5)  4(%10.0)  a=ns, b=ns, c=ns 
Postoperative dialysis   1(%2.5)  3(%7.5)  3(%7.5)  a<0.05, b<0.05, c=ns 
Multiple organ failure   -  -
  1(%2.5)  a=ns, b=ns, c=ns 
Pulmonary complications  -
  4(%10.0)  6(%15)  a<0.05, b<0.05, c=ns 
Arrhythmia   1(%2.5)
  3(%7.5)  5(%12.5)  a<0.05, b<0.05, c=ns 
Mediastinitis   -  -  1(%2.5)  a=ns, b=ns, c=ns 
Transient ischemic episode  -  3(%7.5)  2(%5.0)  a<0.05, b<0.05, c=ns 
Transient hemiparesia  -  2(%5.0)  3(%7.5)  a<0.05, b<0.05, c=ns 
Permanent hemiplegia  -  2(%5.0)
  2(%5.0)  a<0.05, b<0.05, c=ns 
Stroke  -  2(%5.0)  3(%7.5)  a<0.05, b<0.05, c=ns 
Low cardiac output   1(%2.5)  4(%10.0)  3(%7.5)  a<0.05, b<0.05, c=ns 
Reexploration for bleeding   2(%5)  3(%7.5)  4(%10.0)  a<0.05, b<0.05, c=ns 
Wound infection   1(%2.5)  1(%2.5)  1(%2.5)  a=ns, b=ns, c=ns 
CEA: Carotid endarterektomy, CABG: Coronary arterial bypass greft 
ns: not significant,  
a: p value for group Only CABG versus group Combined CEA+ CABG. 
b: p value for group Only CABG versus group Staged CEA+ CABG. 
c: p value for group Combined CEA+ CABG versus group Staged CEA+ CABG. 12    The Open Cardiovascular Medicine Journal, 2009, Volume 3  Iyem and Buket 
DISCUSSION 
  The prevalence of significant carotid disease in the car-
diac surgical population reflects the systemic nature of the 
atherosclerotic process. In an analysis of 1779 patients, 
14.7% have 50% or greater stenosis and 6.3% have 75% or 
greater carotid artery stenosis. Carotid artery stenosis grater 
than 50%, redo surgery, peripheral vascular disease, longer 
pump time and hypercholesterolemia were found to be inde-
pendently associated with an increased risk of the stroke and 
mortality [13]. D’agostino, et al. [14] assessed the incidence 
and risk factors of stroke in 1835 patients undergoing CABG 
and found that corotid stenosis>50% was a risk factor in this 
population. It was found that, mortality rate of combined 
CEA plus CABG was 2-12%, and stroke rate in this group of 
patients was 1-15% [15-18]. When staged and combined 
surgeries were compared different results were given accord-
ing to clinics and years. Borger et al. [19] were studied 16 
different studies which are made on 844 combined and 920 
staged surgeries. They found stroke rate as 6% in combined 
surgery and 3.2% in staged surgery. They found death rate as 
4.7% in combined surgery and as 2.9% in staged surgery; 
and no statistically significant difference was reported in 
terms of these variables between two groups. However, Ha-
mulu et al. [20] found stroke rate as 2.3% in combined sur-
gery and as 3.0% in staged surgery; and there were no statis-
tically significant difference in stroke rate between two 
groups and in addition, the death rate was found higher in 
combined surgery group compared staged group (5.7% vs. 
1.5%, p<0.05). In present study, we found the similar results. 
The stroke rate was similar in both groups of combined and 
staged surgery (5% vs %7.5 p>0.05). In addition, the mortal-
ity rate also was similar in both groups (7.5% in combined 
and 10% in staged group p>0.05). These results showed that 
the mortality increases independently from staged or com-
bined surgery was performed in patients undergoing CABG 
plus CEA. The studies evaluated the efficacy and complica-
tions seen during perioperative and postoperative terms of 
combined CEA plus CABG were shown on Table 7 [21-34]. 
  The advantages of combined surgery such as shorter hos-
pitalization period [35], lower cost [25], acceptable early 
mortality and morbidity [36, 37], lower stroke risk on long 
term period [37, 38] were reported. However, there are sev-
eral studies reported the disadvantages of combined surgery 
such as higher stroke and death rates compared to staged 
Table 6.  Factors Affecting Mortality on Multivariate Logistic Regression Analysis  
  Variable Estimate  Standard Error  P Value  Odds Ratio  95% CI 
Preoperative history of cerebrovascular disease  0.074 0.033 0.0002  1.05  1.021-1.125 
Left main coronary arterial lesion  0.772  0.329  0.038  2.20  1.012-4.241 
Postoperative stroke  0.819  0.519  0.035  2.23  1.075-5.556 
 
Table 7.  The Studies on Combined CEA+CABG and Complication Rates 
Author  Year  Patients (n=)  Mean Age (y)  Death (%)  Stroke  (%) 
Pome [21]  1991  52  61  0  5.7 
Rizzo [22]  1992  127  65  5.5  5.5 
Vermeulen [23]  1992  230  63  3.5  3.0 
Chang [24]  1994  189  66  2.0  1,0 
Akins [25]  1995  200  67  2.5  3.0 
Daily [26]  1996  100  68  4.0  0 
Mackey [27]  1996  100  68  8.0  9.0 
Trachiotis [28]  1997  88  68  3.4  3.4 
Takach [29]  1997  255  65  3.9  3.9 
Horst [30]  1999  63  64  7.9  0 
Plestis [31]  1999  213  65  5.6  5.1 
Gott [32]  1999  55  66  5.4  3.6 
Hamulu [20]  2000  88  66  5.7  2.3 
Dylewsky [33]  2001  33  68  6.1  0 
Zacharias [34]  2002  189  69  2.6  2.6 
Kolh [35]  2006  311  67  6  7 
Our study  2007  40  69  7.5  5 
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surgery in current literature [39]. So, the management of 
concurrent carotid and coronary artery disease is controver-
sial because of lack of prospective randomized trials evaluat-
ing the advantages or disadvantages of both surgeries. In our 
study there were no statistically significant difference be-
tween three groups in term of folow-up time in intensive care 
unit and hospitalisation periods. However, mortality and 
morbidity were significantly lower in isolated CABG group 
compared CEA plus CABG groups [40].  
 Borger  et al. [19] concluded that trials must be conducted 
by 1500 patients if we accept expected stroke and death rate 
as %7.5 to get enough results by randomised trials. Recently 
advancing techniques such as carotid angioplasty and stent-
ing, are also alternative techniques in risky patients undergo-
ing cardiac surgery. Timaran et al. [41] evaluated outcomes 
of carotid artery stenting(CAS) before CABG versus com-
bined CEA and CABG and assessed the risk for adverse 
events in 27,084 cases of concurrent carotid revasculariza-
tions and CABG and found that patients undergoing CAS-
CABG had fewer major adverse events than those undergo-
ing CEA-CABG. CAS-CABG patients had a lower incidence 
of postoperative stroke (2.4% vs 3.9%), and combined stroke 
and death (6.9% vs. 8.6%) than the combined CEA-CABG 
group (P < .001), although in-hospital death rates were simi-
lar (5.2% vs 5.4%) and finally they concluded that CAS 
might provide a safer carotid revascularization option for 
patients who require CABG.  
  In a study reported by Hertzer, et al. [42] 129 unstable 
coronary bypass patients with unilateral, asymptomatic ca-
rotid lesions were prospectively randomized to receive either 
combined operations or CABG alone followed by delayed 
endarterectomy. The risk of stroke was 2.8% for the com-
bined operations, whereas that for patients in whom delayed 
CEA was performed within 2 weeks was 14.4% (6.9% at the 
time of coronary grafting and 7.5% at the time of delayed 
carotid operation). Brenner, et al. [43] examined the issue of 
combined and staged CABG / CEA. They demonstrated that 
staged procedures may result in a higher risk of myocardial 
infarction, particularly in the perioperative period of the ca-
rotid operation, with no difference in stroke rates. Indeed 
they found a very high incidence of stroke in patients under-
going such “reverse-staged” procedures. 
  If the combined procedure does indeed result in a higher 
risk of stroke or death, there are several possible reasons. 
One reason may be that the combined procedures are more 
technically difficult, from both a surgical and an anesthetical 
point of view, resulting in more perioperative complications. 
Another reason may be that combined operations result in 
excessive stress on the cardiovascular and cerebrovascular 
systems, resulting in large fluctuations in patient hemody-
namics during relatively long operative procedures. 
CONCLUSION 
  We think that the results of staged or combined CABG 
plus CEA surgery are satisfactory in patients with severe 
carotid disease and advanced coronary artery disease. How-
ever, the mortality and morbidity in both procedures are 
higher than those of alone. 
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